Managing Health Risks in Psychiatric Patients: Practical Clinical Interventions
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on clinical dialogues with the faculty. Full TextPDF
Clinical Update—New Horizons in Cognitive Function: Beyond Psychotic Symptom Control
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Clinical Psychiatry News.
This Clinical Update is based on faculty interviews. Full TextPDF
NEI Academy Update—Neuroscience: Insights and Applications
A supplement to Clinical Psychiatry News supported by educational grants from Cephalon and Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on presentations made at the 2005 Neuroscience Education Institute Psychopharmacology Academy 2-Day Series held April 30-May 1, 2005, in Cleveland, Ohio. Full TextPDF
NEI Academy Update—Treatment Rationale: Bipolar, Sleep-Related, and Depressive Disorders
A supplement to Clinical Psychiatry News supported by educational grants from Cephalon and Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on presentations made at the 2005 Neuroscience Education Institute Psychopharmacology Academy 2-Day Series held April 30-May 1, 2005, in Cleveland, Ohio. Full TextPDF
Understanding and Managing Metabolic and Other Medical Issues in Psychiatry
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education (EOCME), an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on clinical dialogues with the faculty. Full TextPDF
Psychopharmacology: Beyond Conventional Wisdom
A supplement to Clinical Psychiatry News supported by unrestricted educational grants from Cephalon and Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education, an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on faculty presentations made during the Neuroscience Education Institute's Global Psychopharmacology Congress, February 17-20, 2005, in San Diego, California. Full TextPDF
Advances in the Treatment of Bipolar Disorder and Schizophrenia
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education/Excerpta Medica, Inc., an ACCME accredited provider, and Clinical Psychiatry News.
The articles in this supplement are based on faculty interviews and presentations given at a medical education conference. Full TextPDF
Schizophrenia: More Than Classical Symptoms
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer.
This supplement was jointly sponsored by The Elsevier Office of Continuing Medical Education/Excerpta Medica, Inc., an ACCME accredited provider, and Clinical Psychiatry News. Full TextPDF
Atypical Antipsychotics in Treatment-Resistant Depression
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by Excerpta Medica, Inc., an ACCME accredited provider, and Clinical Psychiatry News.
Highlights of presentations produced from clinical dialogues with the faculty. Full TextPDF
Broadening Horizons: Advances in Understanding the Etiology, Effects, and Treatment of Anxiety Disorders
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from UCB Pharma. This supplement was jointly sponsored by Excerpta Medica, Inc., an ACCME accredited provider, and Clinical Psychiatry News. Full TextPDF
New Findings in Schizophrenia: An Update on Causes and Treatment
A supplement to Clinical Psychiatry News supported by an unrestricted educational grant from Pfizer. This supplement was jointly sponsored by Excerpta Medica, Inc., an ACCME accredited provider, and Clinical Psychiatry News.
Highlights of presentations produced from clinical dialogues with the faculty. Full TextPDF
